Company / Depreciation & Amortization
AIM ImmunoTech Inc. Depreciation & Amortization History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$39.0K
FY2024
5-year range
$38.0K / $665.0K
FY2020-FY2024
Trend
+2.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization returned to growth in FY2024 after 3 years of decline, reaching $39,000.
Based on SEC 10-K filings.
$39,000 in FY2024 with a 3-year CAGR of -61.1%.
Improved from $659,000 to $39,000 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -61.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -61.1%, indicating a declining trend.
- In FY2024, depreciation & amortization increased 2.6% year-over-year.
- Peak depreciation & amortization was recorded in FY2017.
- Lowest depreciation & amortization in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $39.0K | +2.6% |
| FY2023 | $38.0K | -94.2% |
| FY2022 | $659.0K | -0.9% |
| FY2021 | $665.0K | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $941.0K | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026